Divalproex Sodium
Product Images NDC 53808-1065

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 53808-1065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by State Of Florida Doh Central Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image For 250mg (Divalproex 250mg)

This is a prescription medication called Divalproex Sodium. It is in the form of extended-release tablets, each containing 250mg of the active ingredient. The package has a lot number of 251402 and an expiration date of February 8th, 2015. The manufacturer is DOH Cent.*

FDA Label Image

Figure 1 (Divalproex Fig1)

FDA Label Image

Figure 2 (Divalproex Fig2)

FDA Label Image

Figure 3 (Divalproex Fig3)

This is a chart titled "Reduction In CPS Rate" with the caption "Figure 3". It has two axes, one labeled "High Dose" and one labeled "Low Dose", and a line graph depicting the percentage of patients who experienced improvement, no change, or worsening. The chart is measuring the reduction in CPS (chronic pain syndrome) rate.*

FDA Label Image

Figure 4 (Divalproex Fig4)

This is a figure presenting the mean 4-week migraine rates for two studies comparing a placebo treatment with divalproex sodium delayed-release tablets. The mean dose of divalproex sodium delayed-release tablets in the studies was either 500 or 1,000 mg/day or 1,087 mg/day.*

FDA Label Image

Chemical Structure (Divalproex Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.